Meth addiction treatment: how specialist care can help

Meth is a stimulant, and treating stimulant use is different from treating alcohol or opioid dependence. One of the biggest differences is that no substitute medication works in the way methadone works for opioids. Treatment instead focuses on managing withdrawal and stabilising health. From there, psychological support can develop. Research published in the Journal of Internal Medicine has shown that meth has a neurotoxic effect on the brain. This leads to the loss of dopaminergic fibres and affecting the brain’s ability to produce dopamine naturally.

A further study published in PMC found that meth dysregulates both dopamine transmission and dopamine reuptake. In plain terms, the drug floods the brain with dopamine in a way it cannot replicate on its own. When use stops, the brain has to relearn how to produce it. That process takes time. It’s one reason meth is particularly hard to stop without clinical support.

Residential care is not the right option for everyone, but it is often the most effective starting point when meth use is frequent or heavy. It’s also suited for when there are co-occurring mental health symptoms, or when stopping was attempted without lasting success. This type of care removes you from the environment where drug use was prevalent.

A four-to-six week stay is typically the minimum recommended. Research consistently shows that stays of one or two weeks aren’t enough time for the brain to recover neurologically from the effects of meth, or to do the therapeutic work recovery needs.

When home is stable and residential treatment isn’t practical, outpatient care works. Regular sessions with a therapist, clinical check-ins, and a clear relapse prevention plan provide real structure without requiring time away. Regular sessions with a therapist and a clear relapse prevention plan can provide real structure without requiring time away.

Online treatment is also available for people who need flexibility. Our clinical team can advise on whether outpatient care is the right starting point or whether a period of residential support first would be more appropriate.

Unlike alcohol or benzodiazepine withdrawal, meth withdrawal does not usually carry the same acute medical risk. But it is rarely comfortable, and it directly affects motivation, mood, sleep, and the ability to engage in therapy. 

A study by McGregor et al. published in the journal Addiction described two distinct phases. The first was an acute phase in the initial seven to 10 days, characterised by increased sleep, low mood, fatigue, and poor concentration. This was followed by a subacute phase lasting at least a further two weeks, during which sleep quality remains disrupted.

Early clinical support does more than manage discomfort. It lets the team monitor how you’re doing and adjust care as the picture changes. Learn more about drug detox support and what to expect in the early days.

You don’t need to have made any decisions before you get in touch. A confidential addiction assessment is a conversation with one of our clinicians about what has been happening and what level of support might suit you. Nothing is agreed or committed to during that call. It’s simply a chance to get up to speed with your options.

Based on your assessment, our team will recommend a level of care that reflects your pattern of meth use, your mental health, your home environment, and any previous treatment. No two treatment plans look the same, because no two people arrive in the same position.

Therapy is the core of meth addiction treatment. One-to-one sessions with your assigned therapist run alongside group therapy and structured psychoeducational work. Relapse prevention is built in from the start, including practical work on managing cravings and the emotional patterns that drove use.

For people with co-occurring mental health needs, our team integrates mental health support into the treatment plan rather than treating it separately.

The work doesn’t stop at discharge. Continuing care after residential or outpatient treatment helps you maintain progress and navigate early recovery in real life. We work with you on a continuing care plan before you leave, and aftercare for addiction treatment is ready as your needs change over time.

Yes. Research published in PMC found that meth use is closely associated with anxiety and depression, and these often need to be treated at the same time as the addiction itself.  Assessment helps to distinguish between pre-existing mental health conditions and those caused or worsened by meth use, so that both can be planned for.

Not necessarily. The right level of care depends on how much and how often you have been using, your mental health, your home environment, and whether you have tried to stop before. Some people start with residential treatment, others with outpatient. An assessment is the only way to know what level of care is right for you.

There is no approved substitute medication for meth addiction in the way methadone is used for opioid dependence. A 2010 review published in PMC found that multiple medications trialled for meth dependence failed to show clear efficacy. It did show, though, that some agents, including modafinil, bupropion, and naltrexone, had some positive results in reducing use. In practice, treatment focuses on psychological support and clinical monitoring rather than medication-based detox.

The first step is a confidential addiction assessment. This is a private conversation with one of our clinicians about what has been happening and what level of care might suit you. There is no pressure to commit to anything during that conversation. You can contact us by phone or online, and we will take it from there.

es. Castle Health can offer guidance, family therapy, and advice about treatment options for someone in your life. If you are not sure how to start that conversation, or you just want to understand what is available, get in touch. You don’t need to have all the answers before you call.